BRF
DERM icon

B. Riley Financial’s Journey Medical DERM Stock Holding History

B. Riley Financial’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-429,595
Closed -$1.18M – 22
2023
Q3 		$1.18M Sell
429,595
-323,898
-43% -$724K 0.4% 19
2023
Q2 		$1.2M Sell
753,493
-21,303
-3% -$34.3K 0.31% 17
2023
Q1 		$1.22M Sell
774,796
-89,899
-10% -$168K 0.32% 19
2022
Q4 		$1.66M Hold
864,695
– – 0.37% 22
2022
Q3 		$2.13M Hold
864,695
– – 0.38% 21
2022
Q2 		$3.23M Hold
864,695
– – 0.72% 21
2022
Q1 		$4.18M Hold
864,695
– – 0.72% 21
2021
Q4 		$4.65M Buy
+864,695
New +$6.26M 0.52% 21

Other funds holding DERM

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RAG
RIA Advisory Group Des Moines, Iowa $460M AUM 29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

B. Riley Financial's DERM Position: Q4 2023 in Review

B. Riley Financial sold out of Journey Medical (DERM) in Q4 2023, closing a stake of 429,595 shares — an estimated $1.18M sold.

B. Riley Financial first reported a position in DERM in Q4 2021 and held it in 8 quarters. The position peaked at $4.65M in Q4 2021. 36 funds tracked by Wall St. Rank hold DERM as of Q4 2023.

  • B. Riley Financial reported no remaining Journey Medical position as of Q4 2023 after selling out during the quarter.
  • B. Riley Financial sold 429,595 Journey Medical shares in Q4 2023, an estimated $1.18M.
  • B. Riley Financial first reported a position in Journey Medical in Q4 2021 and held it in 8 quarters.
  • B. Riley Financial's Journey Medical position peaked at $4.65M in Q4 2021.
  • 36 funds tracked by Wall St. Rank held Journey Medical as of Q4 2023.

Based on B. Riley Financial's 13F filing for Q4 2023, filed 12 Feb 2024.